Connection
Edward Ashwood to Trisomy
This is a "connection" page, showing publications Edward Ashwood has written about Trisomy.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.584 |
|
|
|
-
Ashwood ER, Palomaki GE. A new era in noninvasive prenatal testing. N Engl J Med. 2013 11 28; 369(22):2164.
Score: 0.413
-
Walker BS, Nelson RE, Jackson BR, Grenache DG, Ashwood ER, Schmidt RL. A Cost-Effectiveness Analysis of First Trimester Non-Invasive Prenatal Screening for Fetal Trisomies in the United States. PLoS One. 2015; 10(7):e0131402.
Score: 0.115
-
Palomaki GE, Wyatt P, Best RG, Lepage N, Ashwood ER, Souers RJ, Thorson JA. Assessment of laboratories offering cell-free (cf) DNA screening for Down syndrome: results of the 2018 College of American Pathology External Educational Exercises. Genet Med. 2020 04; 22(4):777-784.
Score: 0.039
-
Ashwood ER, Cheng E, Luthy DA. Maternal serum alpha-fetoprotein and fetal trisomy-21 in women 35 years and older: implications for alpha-fetoprotein screening programs. Am J Med Genet. 1987 Mar; 26(3):531-9.
Score: 0.016